RxDoctor Payments Data

Josefina Romaguera, MD

Obstetrics & Gynecology · Hato Rey, PRNPI 1295863843

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,250 of the $3,380 with a category attached, or 66.6%. Merck accounts for 79.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,664 and has fallen 92.3% since, to $129 in 2025. Among obstetrics & gynecology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,380in general payments, 2019–2025

Across 15 payments — averaging $225.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3K
  • AbbVie$204
  • Roche Diagnostics Corporation$121
  • Hologic Sales And Service, LLC$109
  • Hologic Inc$101
  • Boston Scientific$89
  • plus $73 from 2 others
$262,482in research payments, 2019–2025

Across 90 payments — averaging $2916.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$262K
  • Merck$0

What the payments were for

  • Consulting fees$2,25067%
  • Food & beverage$1,13033%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,380 in reported general payments places this provider in the 90th percentile of 333 obstetrics & gynecology providers in Puerto Rico.

See all obstetrics & gynecology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$2,194
Medicare patients
16
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol25$1,894
ProgesteroneProgesterone, Micronized13$331
Alendronate Sodium17$92

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Hato Rey

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →